No Data
Teleflex 13G Filing Shows Janus Henderson Group Plc Reported A 10.3% Stake In The Company As Of November 30, 2023
Madrigal Pharmaceutical 13G Filing Shows Janus Henderson Group PLC Holds 15.4% Stake In Company As Of September 29, 2023
Soleno Therapeutics 13G Filing Shows Janus Henderson Group Plc Holds 10.1% Stake In Co
Janus Henderson Group Plc Reported 10.5% Passive Stake In Ardelyx in 13G Filing As Of Dec 30, 2022
RBC Cuts Price Target on Brookfield Asset Management to $61 From $66, Maintains Outperform Rating
Asset Management One Co. Ltd. Trims Stock Holdings in Organon & Co. (NYSE:OGN)